Maplelane Capital’s Cognizant CTSH Stock Holding History

Maplelane Capital’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1	Closed	–	–	144
2015 Q1	$0	Buy	+1	New	+$59	﹤0.01%	160
2013 Q4	–	Sell	-80,000	Closed	-$3.29M	–	131
2013 Q3	$3.29M	Sell	80,000 -33,862	-30%	-$1.26M	0.14%	116
2013 Q2	$3.57M	Buy	+113,862	New	+$3.78M	0.22%	78

Other funds holding CTSH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

Maplelane Capital's CTSH Position: Q2 2015 in Review

Maplelane Capital sold out of Cognizant (CTSH) in Q2 2015, closing a stake of 1 share.

Maplelane Capital first reported a position in CTSH in Q2 2013 and held it in 3 quarters. The position peaked at $3.57M in Q2 2013. 810 funds tracked by Wall St. Rank hold CTSH as of Q2 2015.

Maplelane Capital reported no remaining Cognizant position as of Q2 2015 after selling out during the quarter.
Maplelane Capital sold 1 Cognizant share in Q2 2015.
Maplelane Capital first reported a position in Cognizant in Q2 2013 and held it in 3 quarters.
Maplelane Capital's Cognizant position peaked at $3.57M in Q2 2013.
810 funds tracked by Wall St. Rank held Cognizant as of Q2 2015.

Based on Maplelane Capital's 13F filing for Q2 2015, filed 14 Aug 2015.